Categories
Market Reports Market Study News

Gene Therapy Market Industry Growth With High CAGR During Forecast 2020 | Covid-19 Impact

The Business Research Company’s Gene Therapy Market Global Report 2020-30: Covid 19 Growth and Change. The report covers market size, key players, market share and trends to 2030.

Gene Therapy Market Global Report 2020-30: Covid 19 Growth and Change is one of a series of new reports from The Business Research Company that provide Gene Therapy market overviews, analyze and forecast market size and growth for the whole market, Gene Therapy market segments and geographies, Gene Therapy market trends, Gene Therapy market geographies. The report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Read More On The Gene Therapy Market Here –
https://www.thebusinessresearchcompany.com/report/gene-therapy-market-global-report-2020-30-covid-19-growth-and-change

The gene therapy market consists of sales of gene therapy related services by entities (organizations, sole traders and partnerships) that manufacture gene therapy drugs. Gene therapy is used to replace faulty genes or add new genes to cure disease or improve the body`s ability to fight disease. Only goods and services traded between entities or sold to end consumers are included.

Request A Sample For The Gene Therapy Market Report Now –
https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

The global gene therapy market is expected to decline from $3.22 billion in 2019 to $3.18 billion in 2020 at a compound annual growth rate (CAGR) of -1.30%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The market is then expected to recover and reach $6.84 billion in 2023 at a CAGR of 29.09%.

Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World’s Most Comprehensive Database
The Business Research Company’s flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_Info

Categories
News

Gene Therapy Market gaining traction due to new market developments, says Polaris Analysts

Polaris Market Research recently updated its existing market research study on the Gene Therapy Market and estimates that the market would reach USD 4,300 million by 2021. The report provides historical data along with forecast till 2026. The report covers market trends, drivers and opportunity analysis and provides competitor benchmarking information. The report covers an exhaustive list of market tables and figures, thus providing in-depth analytical data for segments across different regions.

The updated report on the Gene Therapy Market is segmented by Therapeutics and by Regions. Major companies covered in the report include:

  • Novartis Pharmaceuticals Corporation
  • Kite Pharma, Incorporated
  • Spark Therapeutics, Inc
  • GlaxoSmithKline
  • Adaptimmune
  • Bluebird bio
  • Celgene
  • Shanghai Sunway Biotech
  • Shenzhen SiBiono GeneTech
  • SynerGene Therapeutics

 

For more information, request a sample of the study on https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/request-for-sample

The study evaluates the overall Gene Therapy Market by the following segments:

  • Historical Marketed Gene Therapies [2003-2012]
    • Rexin-G (Epeius Biotechnologies Corporation)
    • Gendicine (SiBiono GeneTech Co., Ltd)
    • Neovasculgen [Human Stem Cells Institute (HSCI))
    • Glybera (UniQure Biopharma B.V.)
  • First Countries to get an access to Gene Therapies
    • Philippines for Rexin-G [2003]
    • China for Gendicine [2003]
    • Russia for Neovasculgen [2011]
    • Selected European Countries for Glybera

 

The report attributes are as follows:

  • Historical Data (Actuals): 2015, 2016, 2017
  • Base Year: 2016
  • Estimates & Forecast: 2019 to 2021

The report can be customized on the basis of regional analysis, segment analysis, industry outlook and competitive analysis. Some of the major focus points which are covered in the report include:

  • Industry Trends, opportunity and challenges in the market
  • Role of key players across the value chain
  • End-User analysis to define the market strategy
  • Competitive mapping
  • Regional and country level breakdown

These insights are included in the report which would help you to have a realistic overview of the overall market including the competition, investment opportunities, restraints and challenges, regulatory factors which might affect the market growth. Moreover, the report would help to identify the regional market growth opportunities for different segments covered in the report.

Speak to Analyst to know more @ https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/speak-to-analyst

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Contact Us

Polaris Market Research

Phone: +44-203-287-6050

Email: [email protected]

Web: www.polarismarketresearch.com

Categories
News

Gene Therapy Market gaining traction due to new market developments, says Polaris Analysts

Polaris Market Research recently updated its existing market research study on the Gene Therapy Market and estimates that the market would reach USD 4,300 million by 2021. The report provides historical data along with forecast till 2026. The report covers market trends, drivers and opportunity analysis and provides competitor benchmarking information. The report covers an exhaustive list of market tables and figures, thus providing in-depth analytical data for segments across different regions.

The updated report on the Gene Therapy Market is segmented by Therapeutics and by Regions. Major companies covered in the report include:

  • Novartis Pharmaceuticals Corporation
  • Kite Pharma, Incorporated
  • Spark Therapeutics, Inc
  • GlaxoSmithKline
  • Adaptimmune
  • Bluebird bio
  • Celgene
  • Shanghai Sunway Biotech
  • Shenzhen SiBiono GeneTech
  • SynerGene Therapeutics

 

For more information, request a sample of the study on https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/request-for-sample

The study evaluates the overall Gene Therapy Market by the following segments:

  • Historical Marketed Gene Therapies [2003-2012]
    • Rexin-G (Epeius Biotechnologies Corporation)
    • Gendicine (SiBiono GeneTech Co., Ltd)
    • Neovasculgen [Human Stem Cells Institute (HSCI))
    • Glybera (UniQure Biopharma B.V.)
  • First Countries to get an access to Gene Therapies
    • Philippines for Rexin-G [2003]
    • China for Gendicine [2003]
    • Russia for Neovasculgen [2011]
    • Selected European Countries for Glybera

 

The report attributes are as follows:

  • Historical Data (Actuals): 2015, 2016, 2017
  • Base Year: 2016
  • Estimates & Forecast: 2019 to 2021

The report can be customized on the basis of regional analysis, segment analysis, industry outlook and competitive analysis. Some of the major focus points which are covered in the report include:

  • Industry Trends, opportunity and challenges in the market
  • Role of key players across the value chain
  • End-User analysis to define the market strategy
  • Competitive mapping
  • Regional and country level breakdown

These insights are included in the report which would help you to have a realistic overview of the overall market including the competition, investment opportunities, restraints and challenges, regulatory factors which might affect the market growth. Moreover, the report would help to identify the regional market growth opportunities for different segments covered in the report.

Speak to Analyst to know more @ https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/speak-to-analyst

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Contact Us

Polaris Market Research

Phone: +44-203-287-6050

Email: [email protected]

Web: www.polarismarketresearch.com

Categories
Analysis Forecast Market Price Analysis Market Reports Market Size

Gene Therapy Market Analytical Overview, Growth Factors, Demand and Trends Forecast to 2026

Polaris Market Research recently updated its existing market research study on the Gene Therapy Market and estimates that the market would reach USD 4,300 million by 2021. The report provides historical data along with forecast till 2026. The report covers market trends, drivers and opportunity analysis and provides competitor benchmarking information. The report covers an exhaustive list of market tables and figures, thus providing in-depth analytical data for segments across different regions.

The updated report on the Gene Therapy Market is segmented by Therapeutics and by Regions. Major companies covered in the report include:

  • Novartis Pharmaceuticals Corporation
  • Kite Pharma, Incorporated
  • Spark Therapeutics, Inc
  • GlaxoSmithKline
  • Adaptimmune
  • Bluebird bio
  • Celgene
  • Shanghai Sunway Biotech
  • Shenzhen SiBiono GeneTech
  • SynerGene Therapeutics

For more information, request a sample of the study on https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/request-for-sample

The study evaluates the overall Gene Therapy Market by the following segments:

  • Historical Marketed Gene Therapies [2003-2012]
    • Rexin-G (Epeius Biotechnologies Corporation)
    • Gendicine (SiBiono GeneTech Co., Ltd)
    • Neovasculgen [Human Stem Cells Institute (HSCI))
    • Glybera (UniQure Biopharma B.V.)
  • First Countries to get an access to Gene Therapies
    • Philippines for Rexin-G [2003]
    • China for Gendicine [2003]
    • Russia for Neovasculgen [2011]
    • Selected European Countries for Glybera

The report attributes are as follows:

  • Historical Data (Actuals): 2015, 2016, 2017
  • Base Year: 2016
  • Estimates & Forecast: 2019 to 2021

The report can be customized on the basis of regional analysis, segment analysis, industry outlook and competitive analysis. Some of the major focus points which are covered in the report include:

  • Industry Trends, opportunity and challenges in the market
  • Role of key players across the value chain
  • End-User analysis to define the market strategy
  • Competitive mapping
  • Regional and country level breakdown

These insights are included in the report which would help you to have a realistic overview of the overall market including the competition, investment opportunities, restraints and challenges, regulatory factors which might affect the market growth. Moreover, the report would help to identify the regional market growth opportunities for different segments covered in the report.

Speak to Analyst to know more @ https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/speak-to-analyst

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Contact Us

Polaris Market Research

Phone: +44-203-287-6050

Email: [email protected]

Web: www.polarismarketresearch.com

Categories
Analysis Forecast Coronavirus COVID-19 Industry Impact Market Size

Gene Therapy Market Future Forecast Assessed On The Basis Of How The Market Is Predicted To Grow

According to a new report published by Polaris Market Research, the global gene therapy market is anticipated to reach USD 4,300 million by 2021. The demand for gene therapy is primarily driven by continuous technological advancements and successful progression of several clinical trials targeting treatments with strong unmet need.

Moreover, rising R&D spend on platform technologies by large and emerging biopharmaceutical companies and favorable regulatory environment will accelerate the clinical development and the commercial approval of gene therapies in the foreseeable future. Despite promise, the high cost of gene therapy represents a significant challenge for commercial adoption in the forecast period.

Request for sample copy of this report @  https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/request-for-sample

Gene therapy involves inactivating a mutated gene that is not functioning properly and introducing a new gene to assist in fighting a disease. Overall, the field of gene therapy continues to mature and advance with many products in development and nearing commercialization. For instance, Spark Therapeutics received approval of Luxturna, a rare form inherited blindness in December 2017. Gene therapy market in late 2017 also witnessed the approvals of Gilead/Kite Pharma’s Yescarta and Novartis’ Kymriah in the cancer therapeutic area.

Gene therapy offers promise in the treatment of range of indications in cancer and genetic disorders. Large Pharmaceuticals and Biotechnology companies’ exhibit strong interest in this field and key among them include Allergan, Shire, Biomarin, Pfizer and GSK. The gene therapy space is witnessing a wave of partnerships and alliances. Pfizer has recently expanded its presence in gene therapy with the acquisition of Bamboo Therapeutics and Allergan entered the field, with the acquisition of RetroSense and its Phase I/II optogenetic program.

North America holds a dominating position in the global gene therapy market which is followed by Europe and the Asia Pacific. The U.S. has maximum number of clinical trials ongoing followed by Europe. Moreover, the field of gene therapy in the U.S. and Europe continues to gain investor attention driven by success of high visible clinical programs and the potential of gene therapy to address strong unmet need with meaningful commercial opportunity. Moreover, the increasing partnerships and alliances and the disruptive potential of gene therapy bodes well for the sector through the forecast period.

Key Findings from the study suggest products accessible in the market are much competitive and manufacturers are progressively concentrating on advancements to pick up an aggressive edge. Companies are in a stage of development of new items in order to guarantee simple implementation and connection with the current gene. The hospatility segment is anticipated to grow at a high growth rate over the forecast period with the expanding utilization of smart locks inferable from expanding security-related worries among clients amid their stay at the hotels. North America is presumed to dominate the global smart locks market over the forecast years and Asia Pacific region shows signs of high growth owing to the booming economies of India, and China.

Request for Discount on This Report @ https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/request-for-discount-pricing

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Contact us

Mr. Likhil

Corporate Sales, USA

Polaris Market Research

Phone: 1-646-568-9980

Email: [email protected]

Web: www.polarismarketresearch.com

Categories
Analysis Forecast Market Price Analysis Market Reports Market Size News

Gene Therapy Market Growth, SWOT Analysis by Top Vendors and Forecast Report to 2028

Quince Market Insights has recently released a market report which provides an in-depth understanding of various drivers and opportunities that are expected to shape the development of a market for Gene therapy . This report highlights further the structure of the Gene therapy market in several regions and analyzes the business environment in individual regions.

The research report for global Gene therapy market consists of the valuation for a period from 2020 to 2028. The global study on Gene therapy also provides qualitative industry perspectives such as engines, barriers, value chain, regulatory framework and trade statistics. The supply chain of main stages has been studied in depth.

For more information, download sample of the premium report https://www.quincemarketinsights.com/request-sample-60261?utm_source=campaign=Pooja/PF

Quince Market Insights | LinkedIn

The size of the global Gene therapy market is expected to reach USD xxx billion by 2028. During the forecast period, the global Gene therapy market is expected to expand at an x.x per cent CAGR.

In order to provide a deep understanding of different aspects of the Gene therapy market at the granular level, the Gene therapy market is split into several segments. The report illustrates each segment and sub-segment’s growth potential, market size, share, and future prospects.

The report thoroughly discusses important indicators of market growth, such as the analysis of the supply chain, value chain analysis and a compounded annual growth rate. The data presented will allow readers to understand in detail the quantitative and qualitative growth aspects of the Gene therapy market.

Alliance for Regenerative Medicine, Gilead Sciences, Inc., Novartis AG, Sibiono GeneTech Co. Ltd.and others are among the world’s leading players in the Gene therapy business. Such businesses harness the technological advances to extend their product reach and widen their choice of customers. To increase their versatility and willingness to adapt products to customer feedback, businesses are making use of technology to become more customer-centric.

Benefits of this report are-

    • It offers value for competitive level playing, giving the current giants as well as new entries equal status.

    • It will raise understanding of Gene therapy market’s overall outlook.

    • It is a strategic marketing approach to raise organisation, which makes it a totally helpful report, among other competitors.

    • -Helps to understand the current market scenario, as the report gives historical information on the space of the Gene therapy and makes future projections.

    • -The customized market segments will be examined depending on the region, country or even the different manufacturers in the Gene therapy .

Get ToC for the overview of the premium report https://www.quincemarketinsights.com/request-toc-60261?utm_source=campaign=Pooja/PF

Market Segmentation:

By Product:

• Yescarta

• Kymriah

• Luxturna

• Strimvelis

• Gendicine

By Application:

• Ophthalmology

• Oncology

• Adenosine

• Deaminase

• Deficient Severe Combined Immunodeficiency

By Region:

• North America

◦ North America, by Country

▪ US

▪ Canada

▪ Mexico

◦ North America, by Product

◦ North America, by Application

• Western Europe

◦ Western Europe, by Country

▪ Germany

▪ UK

▪ France

▪ Italy

▪ Spain

▪ The Netherlands

▪ Rest of Western Europe

◦ Western Europe, by Product

◦ Western Europe, by Application

• Asia Pacific

◦ Asia Pacific, by Country

▪ China

▪ India

▪ Japan

▪ South Korea

▪ Australia

▪ Indonesia

▪ Rest of Asia Pacific

◦ Asia Pacific, by Product

◦ Asia Pacific, by Application

• Eastern Europe

◦ Eastern Europe, by Country

▪ Russia

▪ Turkey

▪ Rest of Eastern Europe

◦ Eastern Europe, by Product

◦ Eastern Europe, by Application

• Middle East

◦ Middle East, by Country

▪ UAE

▪ Saudi Arabia

▪ Qatar

▪ Iran

▪ Rest of Middle East

◦ Middle East, by Product

◦ Middle East, by Application

• Rest of the World

◦ Rest of the World, by Country

▪ South America

▪ Africa

◦ Rest of the World, by Product

◦ Rest of the World, by Application

ABOUT US:

QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the world’s most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

Contact Us

Quince Market Insights
Ajay D. (Knowledge Partner)
Office No- A109,
Pune, Maharashtra 411028
Phone: APAC +91 706 672 4848 / US +1 208 405 2835 / UK +44 1444 39 0986
Email: [email protected]
Web: www.quincemarketinsights.com

Categories
News

Gene Therapy Market Boosting the Healthcare Industry Worldwide

Transparency Market Research (TMR) has published a new report titled, “Gene Therapy Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global gene therapy market was valued at US$ 17.0 Mn in 2017 and is projected to expand at a CAGR of 40.0% from 2018 to 2026. New product approvals, promising therapeutic outcomes of gene therapy, and high prevalence of non-Hodgkin Lymphoma are anticipated to drive the global market in the next few years. Europe is projected to dominate the global gene therapy market, followed by U.S., by the end of 2026. Potential unmet needs in the fields of oncology, rare genetic disorders in the U.S. and Europe, new product approvals and commercialization, and high clinical R&D budgets are likely to drive the gene therapy market in these regions during the forecast period. The gene therapy market in Rest of World is projected to expand at a significant CAGR during the forecast period. The high growth rate is attributed to the anticipated approval and commercialization of gene therapy products in developed countries such as Japan, Australia & New Zealand, GCC countries, and China, and high prevalence of non-Hodgkin Lymphoma and head and neck cancers.

Request a PDF Sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1838

New product approvals & commercialization drives market

2016, 2017, and 2018 were key milestones in the history of the gene therapy market in the U.S. and Europe, as around four gene therapy products have been approved and commercialized. These products are currently in the infancy stage of commercialization, and have exhibited highly positive therapeutic outcomes. For instance, in May 2016, GlaxoSmithKline (GSK) gene therapy product, Strimvelis, received marketing approval for the treatment of patients with a very rare disease called ADA-SCID (Severe Combined Immunodeficiency, due to Adenosine Deaminase deficiency). Strimvelis is the first ex-vivo stem cell gene therapy to be approved in Europe for the treatment of ADA-SCID. Furthermore, in August 2017, the USFDA approved Novartis AG’s flagship gene therapy product, Kymriah, for the treatment of children and adults up to the age of 25 years affected with B-cell precursor acute lymphoblastic leukemia (ALL). Thus, recent approvals of gene therapy products in the U.S. and Europe for the treatment of various life threatening disorders is projected to fuel the gene therapy market during the forecast period.

Yescarta to be highest revenue generating gene therapy product

The report offers a detailed segmentation of the global gene therapy market based on different gene therapy products approved and commercialized. Based on product, the global gene therapy market has been segmented into Yescarta, Kymriah, Luxturna, Strimvelis, and Gendicine. Yescarta (Axicabtagene Ciloleucel) is a genetically modified autologous Chimeric Antigen Receptor T (CAR T) cell immunotherapy developed by Gilead Sciences, Inc. for the treatment of adult patients with relapsed or refractory large B-cell lymphoma including diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma (PMBCL). It is the first CAR T therapy approved by the US FDA for the treatment of DLBCL. The Yescarta segment is projected to dominate the global gene therapy market by the end of 2026. Anticipated commercialization of Yescarta in Europe and other developed countries and increasing number of treatment centers are key factors that are likely to lead to the dominant share held by Yescarta by the end of 2026.

Request for Analysis of COVID19 Impact on Gene Therapy Markethttps://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1838

Oncology segment to account for high market share

In terms of application, the global gene therapy market has been segmented into ophthalmology, oncology, and adenosine deaminase ?deficient severe combined immunodeficiency (ADA-SCID). The oncology segment is likely to account for a significant share of the market by the end of 2026. Oncology is a highly studied medical field in the clinical pipeline studies of gene therapy candidates. More than 60% of gene therapy clinical research studies are focused on oncology. The large share held by the oncology segment is attributed to the approval and commercialization of Yescarta and Kymriah, in the last one to two years, for the treatment of certain types of non-Hodgkin lymphoma in the U.S. and Europe. Furthermore, increase in demand for Gendicine in China for the treatment of head and neck cancers is projected to drive the segment during the forecast period.

Europe offers high incremental opportunity

The gene therapy market in Europe is projected to expand at a significant CAGR of 30.6% during the forecast period. Large number of patient population with refractory large B-cell lymphoma, including diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma (PMBCL), promising therapeutic outcomes, rising demand for gene therapy treatment, and increasing number of gene therapy treatment centers in Europe are key factors that are likely to fuel the gene therapy market in Europe. Moreover, different pricing models are being evaluated by payers and governments to enable access to high priced gene therapy products. This is likely to drive the demand for gene therapy products in Europe during the forecast period.

Request a PDF Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1838

Large number of clinical pipeline studies and significant investments in gene therapy to gain the first mover advantage

The global gene therapy market is highly consolidated, with very few global players accounting for a major share. Currently, only five companies; Gilead life Sciences Inc. Spark Therapeutic Inc., Novartis AG, Sibiono GeneTech Co. Ltd, and Orchard Therapeutics Limited offer gene therapy products in the market. Most biopharmaceutical companies have invested significantly in clinical R&D for the development of gene therapy products for different chronic and genetic disorders. Large number of gene therapy products are under different stages of clinical pipeline studies, and the number of gene therapy candidates is projected to rise consistently during the forecast period. For instance, according to the Journal of Gene Medicine, there were around 2,597 gene therapy candidates under clinical trials, as of 2017. Of the total clinical studies, around 65% of studies were focused on oncology, 11% of studies were focused on monogenetic field, 7% on infectious diseases and cardiovascular disease, each.

Purchase Gene Therapy Market Reporthttps://www.transparencymarketresearch.com/checkout.php?rep_id=1838&ltype=S

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 Sate Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

Read More Reports: https://www.prnewswire.com/news-releases/global-hemorrhoid-treatment-devices-market-to-grow-at-over-4-6-cagr-from-2018-to-2026-transparency-market-research-301001722.html

 

Categories
News

Gene Therapy Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2027

New Jersey, United States,- The Gene Therapy Market research report added by Verified Market Research is an in-depth analysis of the latest trends, market size, status, upcoming technologies, industry drivers, challenges, regulatory policies, with key company profiles and strategies of players. The research study provides market introduction, Gene Therapy market definition, regional market scope, sales and revenue by region, manufacturing cost analysis, Industrial Chain, market effect factors analysis, Gene Therapy market size forecast, 100+ market data, Tables, Pie Chart, Graphs and Figures, and many more for business intelligence.

The Gene Therapy Market report includes an in-depth analysis of the Gene Therapy market for the present as well as the forecast period. The report encompasses the competition landscape entailing share analysis of the key players in the Gene Therapy market based on their revenues and other significant factors. Further, it covers several developments made by the prominent players of the Gene Therapy market. The Gene Therapy Market report is a beneficial source of perceptive data for a business approach. It presents the market overview with growth analysis together with historical & futuristic costs. Further identifies the revenue, specifications, company profile, demand, and supply data.

Gene Therapy Market was valued at USD 3.69 Billion in 2019 and is projected to reach USD 24.78 Billion by 2027, growing at a CAGR of 26.9% from 2020 to 2027.

Leading Key players of Gene Therapy Market are:

  • Novartis AG
  • Biogen
  • Gilead Sciences
  • MolMed S.p.A.
  • Spark Therapeutics
  • Orchard Therapeutics plc.
  • SIBIONO
  • Bluebird bio
  • Shanghai Sunway Biotech
  • Human Stem Cells Institute

    Gene Therapy Market: Competitive Landscape

    This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

    Gene Therapy Market: Segment Analysis

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Gene Therapy Market, By Product

    • Viral Vectors
    o Adeno-associated virus vectors
    o Retroviral vectors
     Gammaretroviral vectors
     Lentiviral vectors
    o Other viral vectors (herpes simplex and adenoviral vectors)
    • Non-viral Vectors
    o Oligonucleotides
    o Other non-viral vectors (plasmids and RNAi)

    Gene Therapy Market, By Indication

    • Neurological Diseases
    • Cancer
    • Hepatological Diseases
    • Duchenne Muscular Dystrophy
    • Other Indications

    Gene Therapy Market, By Delivery Method

    • Ex vivo
    • In vivo

    Gene Therapy Market: Regional Analysis

    The research report includes a detailed study of regions of North America, Europe, Asia, and South America. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, sales, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.

    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, and Italy)
    Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
    South America (Brazil, Argentina, Colombia, etc.)
    The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

    Why purchase this report

    • The report would provide a comprehensive analysis of the current and future market trends
    • Analysis of both global, regional and country lever markets
    • Key strategic initiatives are taken by major players operating in the Gene Therapy market along with ranking analysis for the key players
    • Analysis based on historical information along with the current trends to estimate the future of the market
    • Analysis of the impact of constantly changing global market scenarios on the market

     

    About us:

    Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals, and critical revenue decisions.

    Our 250 Analysts and SME’s offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.

    Contact us:

    Mr. Edwyne Fernandes

    US: +1 (650)-781-4080
    UK: +44 (203)-411-9686
    APAC: +91 (902)-863-5784
    US Toll-Free: +1 (800)-782—1768

    Email: [email protected]

  • Categories
    News

    Gene Therapy Market Size, Share, Global Future Trend, Segmentation, Business Growth, Top Key Players, Opportunities and Forecast to 2027

    New Jersey, United States,- The most recent Gene Therapy Market Research study includes some significant activities of the current market size for the worldwide Gene Therapy market. It presents a point by point analysis dependent on the exhaustive research of the market elements like market size, development situation, potential opportunities, and operation landscape and trend analysis. This report centers around the Gene Therapy business status, presents volume and worth, key market, product type, consumers, regions, and key players.

    The COVID-19 pandemic has disrupted lives and is challenging the business landscape globally. Pre and Post COVID-19 market outlook is covered in this report. This is the most recent report, covering the current economic situation after the COVID-19 outbreak.

     

    Key highlights from COVID-19 impact analysis:

    • A summary of the COVID-19 pandemic on the global economy.
    • Fluctuations in the demand and supply chain of the industry.
    • Pre and post-COVID-19 impact on the revenue matrix.

    Unveiling a brief about the Gene Therapy market competitive scope:

  • Bluebird Bio
  • Sangamo
  • Dimension Therapeutics
  • Avalanche Bio
  • Spark Therapeutics
  • Advantagene
  • Celladon
  • Vical Inc.

    The report includes pivotal details about the manufactured products, and in-depth company profile, remuneration, and other production patterns.

    The research study encompasses information pertaining to the market share that every company holds, in tandem with the price pattern graph and the gross margins.

    Gene Therapy Market, By Type

  • Ex vivo
  • In Vivo

    Gene Therapy Market, By Application

  • Cancer
  • Monogenic
  • Infectious disease
  • Cardiovascular disease
  • Other

    Other important inclusions in the Gene Therapy market report:

    • Key player players profiled in the Gene Therapy market
    • The report uncovers the production patterns and remuneration of each company across their territories.
    • In-depth company profile along with remuneration, pricing model, gross margins, and all other financial aspects are given as well.
    • Revenue share and sales volume estimates of each product type are validated in the report.
    • Substantial information concerning the production pattern, growth rate, and market share of each product type over the analysis period are underlined.
    • The research document also divides the Gene Therapy market based on the application scope.
    • The market share of each application together with their individual growth rate are listed.
    • Insights about the competitive dynamics, along with an analytical review of the industry supply are provided.
    • It further includes Porter’s five forces analysis as well as SWOT analysis to evaluate the feasibility of a new project.

     

    A brief overview of the regional landscape:

    • From a geographical perspective, the Gene Therapy market is partitioned into

      North America
      o U.S.
      o Canada
      o Mexico
      Europe
      o Germany
      o UK
      o France
      o Rest of Europe
      Asia Pacific
      o China
      o Japan
      o India
      o Rest of Asia Pacific
      Rest of the World

    • Contribution of each regional market, along with their projected growth rate over the evaluation period are contained in the report.
    • Sales amassed, revenue generated, and market share of each geography is also recorded.

    Reasons To Buy:

    • Analyzing the outlook of the market with the recent trends and SWOT analysis
    • Market dynamics scenario, along with growth opportunities of the market in the years to come
    • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
    • Regional and country-level analysis integrating the demand and supply forces that are influencing the growth of the market.
    • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
    • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
    • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

     

    About Us:

    Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

    Contact Us:

    Mr. Steven Fernandes

    Market Research Intellect

    New Jersey ( USA )

    Tel: +1-650-781-4080

  • Categories
    Coronavirus Market Reports News

    Gene Therapy Market: Detailed survey of the key competitors and the leading players

    According to a new report published by Polaris Market Research, the global gene therapy market is anticipated to reach USD 4,300 million by 2021. The demand for gene therapy is primarily driven by continuous technological advancements and successful progression of several clinical trials targeting treatments with strong unmet need.

    Moreover, rising R&D spend on platform technologies by large and emerging biopharmaceutical companies and favorable regulatory environment will accelerate the clinical development and the commercial approval of gene therapies in the foreseeable future. Despite promise, the high cost of gene therapy represents a significant challenge for commercial adoption in the forecast period.

    Request for sample copy of this report @  https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/request-for-sample

    Gene therapy involves inactivating a mutated gene that is not functioning properly and introducing a new gene to assist in fighting a disease. Overall, the field of gene therapy continues to mature and advance with many products in development and nearing commercialization. For instance, Spark Therapeutics received approval of Luxturna, a rare form inherited blindness in December 2017. Gene therapy market in late 2017 also witnessed the approvals of Gilead/Kite Pharma’s Yescarta and Novartis’ Kymriah in the cancer therapeutic area.

    Gene therapy offers promise in the treatment of range of indications in cancer and genetic disorders. Large Pharmaceuticals and Biotechnology companies’ exhibit strong interest in this field and key among them include Allergan, Shire, Biomarin, Pfizer and GSK. The gene therapy space is witnessing a wave of partnerships and alliances. Pfizer has recently expanded its presence in gene therapy with the acquisition of Bamboo Therapeutics and Allergan entered the field, with the acquisition of RetroSense and its Phase I/II optogenetic program.

    North America holds a dominating position in the global gene therapy market which is followed by Europe and the Asia Pacific. The U.S. has maximum number of clinical trials ongoing followed by Europe. Moreover, the field of gene therapy in the U.S. and Europe continues to gain investor attention driven by success of high visible clinical programs and the potential of gene therapy to address strong unmet need with meaningful commercial opportunity. Moreover, the increasing partnerships and alliances and the disruptive potential of gene therapy bodes well for the sector through the forecast period.

    Key Findings from the study suggest products accessible in the market are much competitive and manufacturers are progressively concentrating on advancements to pick up an aggressive edge. Companies are in a stage of development of new items in order to guarantee simple implementation and connection with the current gene. The hospatility segment is anticipated to grow at a high growth rate over the forecast period with the expanding utilization of smart locks inferable from expanding security-related worries among clients amid their stay at the hotels. North America is presumed to dominate the global smart locks market over the forecast years and Asia Pacific region shows signs of high growth owing to the booming economies of India, and China.

    Request for Discount on This Report @ https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/request-for-discount-pricing

    About Polaris Market Research

    Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

    Contact us

    Mr. Likhil

    Corporate Sales, USA

    Polaris Market Research

    Phone: 1-646-568-9980

    Email: [email protected]

    Web: www.polarismarketresearch.com